We asked Dr. Greg Licholai, a lecturer at Yale SOM and and a biotech entrepreneur, what other healthcare startups can learn from the Theranos debacle.
U.S. regulators have proposed revising the Volcker rule, which restricts the ability of banks to make risky trades with money from depositors. We asked Yale SOM’s Andrew Metrick about the potential consequences of the change.
A change to European privacy rules has unleashed a flood of emails about updated privacy policies to customers all over the world. We asked Yale SOM’s David Bach why.
There is increasing evidence that isolation has a powerful negative effect on health and productivity. We asked Yale SOM’s Marissa King, an expert on social networks, how we can reinforce the connections that help sustain us.
What does the Facebook-Cambridge Analytica scandal say about the risks of trusting Facebook and other tech companies with our data? We talked with Yale Law School's Jack Balkin.
What kind of leader can step in and effectively run an organization that delivers healthcare to millions of veterans? We asked Dr. Howard Forman, an expert in healthcare leadership and policy.
It’s nearly Tax Day, which means we're scrambling to find receipts and puzzling through tax forms. Is all this misery really the best way to pay for public goods?
We asked Prof. William B. English, who spent more than two decades as an economist at the Fed, to interpret new Fed chair Jerome Powell's first Open Market Committee meeting.
With legislators demanding answers from Facebook and users deleting the company's app, its top leaders have been silent. We asked Prof. Jeffrey Sonnenfeld how they should be responding to the Cambridge Analytica scandal.
Should for-profit corporations be taking a stand on a hot-button political issue like guns? Prof. Jeffrey Sonnenfeld argues that businesses need to not just respond but to lead.